HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Previous close
$0.0060
Day range
$0.0060 - $0.0070
Year range
$0.0060 - $0.039
Market cap
5.67M AUD
Avg Volume
3.01M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | -1.76M | -334.83% |
Operating expense | 5.75M | -22.41% |
Net income | -7.49M | -5.68% |
Net profit margin | 426.27 | 145.00% |
Earnings per share | — | — |
EBITDA | -7.21M | -12.28% |
Effective tax rate | -0.55% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.05M | 29.22% |
Total assets | 15.27M | -31.74% |
Total liabilities | 12.80M | -23.40% |
Total equity | 2.47M | — |
Shares outstanding | 905.15M | — |
Price to book | ∞ | — |
Return on assets | -122.92% | — |
Return on capital | -760.03% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -7.49M | -5.68% |
Cash from operations | -1.43M | 21.26% |
Cash from investing | -11.72K | 81.66% |
Cash from financing | 1.19M | -4.10% |
Net change in cash | -236.20K | 62.61% |
Free cash flow | -4.27M | -28.50% |
About
Founded
2020
Website
